APA (7th ed.) Citation

PharmD, K. B., Toral Patel PharmD, B., Toby Trujillo PharmD, F., (ASCP), M. M. M., MD, S. L., MD, H. K., . . . Tyree H. Kiser PharmD, F. Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients. SAGE Publishing.

Chicago Style (17th ed.) Citation

PharmD, Kaitlin Blotske, BCPS Toral Patel PharmD, FCCP Toby Trujillo PharmD, Matthew Marlar MLS (ASCP), Stuart Lind MD, Henry Kramer MD, Kathryn Hassell MD, and FCCM Tyree H. Kiser PharmD. Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients. SAGE Publishing.

MLA (9th ed.) Citation

PharmD, Kaitlin Blotske, et al. Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients. SAGE Publishing.